© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Pefloxacin Mesylate stands out as an antibacterial compound, developed in response to a growing need for effective infection control. Belonging to the quinolone class, it presents strong action against a range of gram-negative and gram-positive bacteria. Its roots trace back to the search for broad-spectrum antibiotics capable of disrupting DNA gyrase in microorganisms. Practical applications pop up in both clinical and laboratory environments, cementing this chemical’s relevance across multiple sectors.
Anyone handling Pefloxacin Mesylate expects to find it as a white to pale yellow crystalline powder. Its form feels gritty, sometimes resembling flakes or tiny pearls, depending on granulation and storage. Water solubility remains moderate. Ethanol and methanol break it down a bit faster. The compound’s density averages close to 1.5 g/cm³, with a melting point held steady between 190°C – 195°C. No strong odors leak from the container, so it leaves a relatively inert impression on the senses. In solution, clarity signals purity—cloudiness raises manufacturing or contamination concern. The pure solid resists caking yet draws in moisture over time, making airtight storage almost routine among professionals.
The chemical formula for Pefloxacin Mesylate is C17H20FN3O3·CH4O3S. The backbone structure contains a fluoroquinolone ring, with nitrogen and oxygen groups increasing its affinity for bacterial enzymes. The mesylate group aids solubility and stability. Molecular weight clocks in at about 415.4 g/mol for the mesylate salt. Molecular diagrams—highly technical in research papers—help scientists predict reactions, but in real life, most see only the off-white powder in its container. Still, the underlying arrangement drives both its antibacterial strength and its interaction with other compounds.
Manufacturers ship Pefloxacin Mesylate in bulk or as smaller packets, consistently observing strict standards for purity and contamination. Typical assays require at least 98% purity by HPLC, with single-compound content and controlled residual solvent levels. Packaged powders may range from 10 grams up to 25 kilograms, depending on end-user demand. Proper labeling includes batch numbers, assay values, storage recommendations, and any required hazard symbols. Hazard classification falls under specific chemical regulations, requiring users to read through Material Safety Data Sheets for exposure guidelines and first-aid procedures.
International shipping relies on customs codes for every product, and for Pefloxacin Mesylate, the Harmonized System (HS) Code lands most frequently at 29419090, under 'Other alkaloids and their derivatives; salts thereof'. This code streamlines clearance and aligns with import regulations targeting chemical substances. Importers and exporters must flag this code on every invoice to avoid penalties and smooth customs clearance.
Form defines use in the field. Most labs and production facilities receive Pefloxacin Mesylate as fine powder, solid at room temperature, packaging designed for low-waste transfer and accurate measuring. Pearls, rarely used, cater to automatic feeding systems where dust creation must stay minimal. Flakes appeal where dissolution speed and surface area boost mixing. Liquids arrive as ready-made solutions, often as trial samples sent for immediate analysis. Crystals—gleaming and angular—turn up mostly in research circles, their size and clarity signaling batch quality. Each form prompts unique handling: powders call for masks, solids for gloves, solutions for eye protection.
Though developed to address human health concerns, Pefloxacin Mesylate poses its own risks. Users report mild eye and skin irritation during direct contact. Dust, if inhaled, provokes coughing and respiratory discomfort. Accidental ingestion brings nausea and, in rare cases, central nervous system symptoms—especially in those handling raw materials for long stretches. Long-term exposure without protection can sensitize skin or provoke allergic reactions. Chemical residues affect water systems when flushed improperly, impacting local aquatic life. Regulations require spill-handling kits on-site and clear protocols for accidental exposure. Strict adherence to recommended storage temperatures—between 2–8°C—prolongs stability while avoiding moisture damage. Personal anecdote: During one stint in an R&D lab, gloves and masks hung by every station, not from paranoia, but longstanding experience with accidental splashes and powder exposures. Chemical safety trainers never stopped reiterating these habits.
Global demand for Pefloxacin Mesylate spikes seasonally with infection outbreaks. Hospitals, clinics, and pharmaceutical manufacturers lean on it for first-line antibiotics, pre-mixed with excipients and binders. Research institutions rely on its pure form for experimental work on bacterial resistance. Veterinary sectors also tap into the raw material, formulating targeted drugs for livestock and companion animals. Each batch faces stringent inspection before release to produce tablets, suspensions, or injectable solutions. This chemical plays a big part in each step, making the supply of high-purity, well-documented raw material make-or-break for downstream products. Anyone who’s managed a pharmaceutical line knows the impact when a single batch comes up out-of-spec: delays cascade, and patient care takes a hit unless contingency stockpiles exist.
Increasing scrutiny from environmental regulators and healthcare watchdogs pushes the sector to develop safer disposal methods, limit waste, and manage resistance. Researchers invest in better filtration systems to catch active residues, while quality assurance teams tighten monitoring for cross-contamination. Automation speeds up weighing and mixing, shrinking human exposure. Updating material labeling with QR codes offers easier tracking and recall efficiency, something impossible with old paper logs. My years in industry make clear that collaboration across disciplines brings the surest improvement—not only to product quality but to the health of workers and patients affected by each run of Pefloxacin Mesylate down the supply chain.
